SCHEMBL7963912

SCHEMBL7963912

Oc1ccccc1CC1CCCC=C1c1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.64
PTGIR P43119 5/20 0.64
PTGER1 P34995 1/20 0.64
PTGER3 P43115 1/20 0.56
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NR4A2 P43354 7/20 0.35
NR4A1 P22736 2/20 0.35
NR4A3 Q92570 2/20 0.35
RXRA P19793 2/20 0.34
RXRB P28702 2/20 0.34
RXRG P48443 2/20 0.34
TRPA1 O75762 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
FABP4 P15090 2/20 0.34
FABP3 P05413 1/20 0.34
ABCC4 O15439 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486495 0.91 PTGIR (0.61) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7970546 0.87 PTGER4 (0.72) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7990542 0.85 PTGIR (0.76) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7489401 0.85 PTGER4 (0.69) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7493935 0.85 PTGER4 (0.58) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7970537 0.84 PTGIR (0.63) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7488841 0.84 PTGER4 (0.61) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7957705 0.83 PTGIR (0.67) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7959932 0.83 PTGER4 (0.61) PTGER4PTGIRPTGER1PTGER3KDM4E
SCHEMBL7492555 0.83 PTGIR (0.64) PTGER4PTGIRPTGER1PTGER3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed